ETFs Holding CBAY »    CBAY Historical Stock Prices »
CBAY News Video: Thu, Apr 7, 2016, 10:31 AM — Thursday 4/7 Insider Buying Report: ATU, CBAY

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CymaBay Therapeutics is a biopharmaceutical company focused on developing and providing access to therapies for patients with liver and other chronic diseases with unmet medical need. Co.'s pipeline includes three clinical stage product candidates: seladelpar (MBX-8025), which is an agonist of peroxisome proliferator-activated receptor delta for the treatment of primary biliary cholangitis; arhalofenate (MBX-102), which is a dual-acting anti-inflammatory and uric acid lowering agent being developed for the treatment of gout; and MBX-2982, which is an oral, G-protein coupled receptor (GPR119) agonist being evaluated as a therapeutic agent for an undisclosed therapeutic indication. Self directed investors in CymaBay Therapeutics Inc will be interested in keeping up with all CymaBay Therapeutics Inc news they can find, both CBAY news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on CBAY. At RediNews, we simplify this task by presenting both CBAY news releases originating from CymaBay Therapeutics Inc itself, and CBAY news from a variety of media outlets. Visitors can browse this news online and through our CBAY RSS news feed.


CBAY News — Articles, Videos, & Press Releases

Noteworthy Friday Option Activity: MDGL, CBAY, QCOM
Friday, May 17, 2019, 3:22 PM — Stock Options Channel
Analysts Anticipate 41% Upside For The Holdings of XPH
Thursday, May 16, 2019, 8:17 AM — ETF Channel
We Did The Math IHE Can Go To $182
Thursday, April 11, 2019, 8:31 AM — ETF Channel
First Week of May 17th Options Trading For CymaBay Therapeutics
Thursday, March 21, 2019, 10:35 AM — Stock Options Channel
Investors Snatch CBAY Even Cheaper Than Its Secondary Stock Offering
Friday, March 8, 2019, 1:15 PM — Dividend Channel
Analysts Expect IHE Will Reach $200
Wednesday, March 6, 2019, 8:29 AM — ETF Channel
Top Buys by Top Brass: Chief Executive Officer Shah's $114.9K Bet on CBAY
Friday, March 1, 2019, 12:06 PM — Dividend Channel
CBAY Crosses Above Key Moving Average Level
Friday, February 22, 2019, 1:48 PM — Market News Video
Analysts Anticipate XPH Will Reach $60
Tuesday, January 29, 2019, 8:00 AM — ETF Channel
Top Buys by Directors: Shah's $114.9K Bet on CBAY
Monday, January 28, 2019, 2:01 PM — Dividend Channel
Interesting CBAY Call Options For February 15th
Tuesday, January 8, 2019, 10:37 AM — Stock Options Channel
Analysts Anticipate XPH To Hit $60
Friday, December 28, 2018, 9:37 AM — ETF Channel
Oversold Conditions For CymaBay Therapeutics (CBAY)
Tuesday, December 18, 2018, 12:13 PM — Dividend Channel
The Math Shows PBSM Can Go To $32
Tuesday, November 27, 2018, 7:34 AM — ETF Channel
First Week of July 2019 Options Trading For CymaBay Therapeutics (CBAY)
Wednesday, November 21, 2018, 11:36 AM — Stock Options Channel
Sum Up The Pieces: ESML Could Be Worth $31
Tuesday, October 23, 2018, 7:35 AM — ETF Channel
First Week of November 16th Options Trading For CymaBay Therapeutics (CBAY)
Monday, October 1, 2018, 10:55 AM — Stock Options Channel
Sum Up The Pieces: DWAS Could Be Worth $66
Wednesday, September 19, 2018, 9:07 AM — ETF Channel
Surprising Analyst 12-Month Target For XPH
Thursday, August 16, 2018, 9:02 AM — ETF Channel
CymaBay Therapeutics is Now Oversold (CBAY)
Friday, July 27, 2018, 2:01 PM — Dividend Channel
Land This Bargain Even Cheaper Than Chief Executive Officer Shah Did
Friday, July 27, 2018, 1:41 PM — Dividend Channel
CymaBay Therapeutics Breaks Below 200-Day Moving Average - Notable for CBAY
Thursday, July 26, 2018, 1:37 PM — Market News Video
First Week of September 21st Options Trading For CymaBay Therapeutics (CBAY)
Wednesday, July 25, 2018, 10:48 AM — Stock Options Channel
Analysts Forecast 20% Upside For The Holdings of XPH
Monday, July 16, 2018, 8:42 AM — ETF Channel
First Week of CBAY August 17th Options Trading
Wednesday, June 20, 2018, 10:57 AM — Stock Options Channel
Implied XPH Analyst Target Price: $55
Friday, June 15, 2018, 9:10 AM — ETF Channel
CBAY is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GEN News

RediNews invites financial news content websites to integrate our XML content for web sites by integrating our RSS feeds found throughout our website wherever news and stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic content is ideal for any financial portal or web portal, from business content web sites to corporate portal intranets. Let RediNews be your content provider of free financial content for news, perfect for location on stock market chart pages by symbol, adding another element of dynamic stock market content to your financial portal. If your web page content already includes elements like SEC filings, screener pages, historical chart information, and other cobranded financial web content, then headlines from RediNews can supplement this dynamic financial content meaningfully.

CBAY News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.